Managed Care Approaches in Optimizing the Impact of PARP Inhibitors on Resource Utilization and Clinical Outcomes in Ovarian Cancer
English
Recorded Courses
hosted by Pharmacy Times Continuing Education (PTCE)
hosted by Pharmacy Times Continuing Education (PTCE)
attend it anywhere online
category
Medicine
Oncology
price
On Book
Managed Care Approaches in Optimizing the Impact of PARP Inhibitors on Resource Utilization and Clinical Outcomes in Ovarian Cancer is organized by Pharmacy Times Continuing Education (PTCE),Release date: October 21, 2022,Expiration date: October 21, 2023,Description:,Ovarian cancer is the leading cause of death in patients diagnosed with gynecologic cancer in the United States. Despite debulking surgery and platinum-based chemotherapy, there is a high rate of recurrence in patients with advanced stage epithelial ovarian cancer. Poly (ADP-ribose) polymerase (PARP) inhibitors demonstrate efficacy as maintenance therapy following response to chemotherapy as well as in treatment of disease recurrence. Managed care pharmacists play a crucial role in appropriate utilization of PARP inhibitors, helping to direct guideline-driven, cost-effective treatment selection for patients with ovarian cancer. This program will explore the emerging role of PARP inhibitors for ovarian cancer and the differences among agents. Considerations for design of oncology clinical pathways and medication therapy management will also be discussed.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Explore the nuances that differentiate the available PARP inhibitors that aid in guiding treatment selection.,• Examine guideline recommendations and the clinical data for the role of PARP inhibitors in various stages of treatment for ovarian cancer.,• Determine the cost of care and utilization management strategies to optimize the use of PARP inhibitors in the treatment of ovarian cancer.